T1 glottic laryngeal cancer: the role of routine follow-up visits in detecting local recurrence

PURPOSE: We assessed the treatment outcome and the benefits of routine follow-up visits in T1 glottic laryngeal squamous cell carcinoma (LSCC). METHODS: Medical records of patients diagnosed with stage T1 glottic LSCC (N = 303) in five Finnish university hospitals between 2003 and 2015 were reviewed...

Descripción completa

Detalles Bibliográficos
Autores principales: Pakkanen, Pihla, Ilmarinen, Taru, Halme, Elina, Irjala, Heikki, Koivunen, Petri, Pukkila, Matti, Ventelä, Sami, Hagström, Jaana, Aaltonen, Leena-Maija
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Laryngology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553688/
https://www.ncbi.nlm.nih.gov/pubmed/34357460
http://dx.doi.org/10.1007/s00405-021-06983-3
Descripción
Sumario:PURPOSE: We assessed the treatment outcome and the benefits of routine follow-up visits in T1 glottic laryngeal squamous cell carcinoma (LSCC). METHODS: Medical records of patients diagnosed with stage T1 glottic LSCC (N = 303) in five Finnish university hospitals between 2003 and 2015 were reviewed. Moreover, data from the Finnish Cancer Registry and the Population Register Center were collected. RESULTS: Of all 38 recurrences, 26 (68%) were detected during a routine follow-up visit, and over half (21 of 38, 55%) presented without new symptoms. Primary treatment method (surgery vs. radiotherapy) was not connected with 5-year disease-specific survival (DSS) or laryngeal preservation rate. CONCLUSION: The majority of recurrences were detected on a routine follow-up visit, and local recurrences often presented without new symptoms. Routine post-treatment follow-up of T1 glottic LSCC seems beneficial. TRIAL REGISTRATION: Trial registration number and date of registration HUS/356/2017 11.12.2017.

Ejemplares similares